These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. T Cell Factor 1-Expressing Memory-like CD8(+) T Cells Sustain the Immune Response to Chronic Viral Infections. Utzschneider DT; Charmoy M; Chennupati V; Pousse L; Ferreira DP; Calderon-Copete S; Danilo M; Alfei F; Hofmann M; Wieland D; Pradervand S; Thimme R; Zehn D; Held W Immunity; 2016 Aug; 45(2):415-27. PubMed ID: 27533016 [TBL] [Abstract][Full Text] [Related]
43. PD-1+ stemlike CD8 T cells are resident in lymphoid tissues during persistent LCMV infection. Im SJ; Konieczny BT; Hudson WH; Masopust D; Ahmed R Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4292-4299. PubMed ID: 32034098 [TBL] [Abstract][Full Text] [Related]
44. The numbers game for virus-specific CD8+ T cells. Doherty PC Science; 1998 Apr; 280(5361):227. PubMed ID: 9565533 [No Abstract] [Full Text] [Related]
46. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. Chen HD; Fraire AE; Joris I; Brehm MA; Welsh RM; Selin LK Nat Immunol; 2001 Nov; 2(11):1067-76. PubMed ID: 11668342 [TBL] [Abstract][Full Text] [Related]
47. Dendritic cells and Stat3 are essential for CD137-induced CD8 T cell activation-induced cell death. Zhang B; Zhang Y; Niu L; Vella AT; Mittler RS J Immunol; 2010 May; 184(9):4770-8. PubMed ID: 20351189 [TBL] [Abstract][Full Text] [Related]
48. Complex Interplay Between MAZR and Runx3 Regulates the Generation of Cytotoxic T Lymphocyte and Memory T Cells. Gülich AF; Rica R; Tizian C; Viczenczova C; Khamina K; Faux T; Hainberger D; Penz T; Bosselut R; Bock C; Laiho A; Elo LL; Bergthaler A; Ellmeier W; Sakaguchi S Front Immunol; 2021; 12():535039. PubMed ID: 33815354 [TBL] [Abstract][Full Text] [Related]
49. mTOR Complex Signaling through the SEMA4A-Plexin B2 Axis Is Required for Optimal Activation and Differentiation of CD8+ T Cells. Ito D; Nojima S; Nishide M; Okuno T; Takamatsu H; Kang S; Kimura T; Yoshida Y; Morimoto K; Maeda Y; Hosokawa T; Toyofuku T; Ohshima J; Kamimura D; Yamamoto M; Murakami M; Morii E; Rakugi H; Isaka Y; Kumanogoh A J Immunol; 2015 Aug; 195(3):934-43. PubMed ID: 26116513 [TBL] [Abstract][Full Text] [Related]
50. Rapamycin-resistant and torin-sensitive mTOR signaling promotes the survival and proliferation of leukemic cells. Park S; Sim H; Lee K BMB Rep; 2016 Jan; 49(1):63-8. PubMed ID: 26497580 [TBL] [Abstract][Full Text] [Related]
52. Novel exosome-targeted T-cell-based vaccine counteracts T-cell anergy and converts CTL exhaustion in chronic infection via CD40L signaling through the mTORC1 pathway. Wang R; Xu A; Zhang X; Wu J; Freywald A; Xu J; Xiang J Cell Mol Immunol; 2017 Jun; 14(6):529-545. PubMed ID: 27264687 [TBL] [Abstract][Full Text] [Related]
53. The Transcription Factor TCF1 Preserves the Effector Function of Exhausted CD8 T Cells During Chronic Viral Infection. Wang Y; Hu J; Li Y; Xiao M; Wang H; Tian Q; Li Z; Tang J; Hu L; Tan Y; Zhou X; He R; Wu Y; Ye L; Yin Z; Huang Q; Xu L Front Immunol; 2019; 10():169. PubMed ID: 30814995 [TBL] [Abstract][Full Text] [Related]
54. Effective T-cell immune responses in the absence of the serine/threonine kinase RIP2. Nembrini C; Reissmann R; Kopf M; Marsland BJ Microbes Infect; 2008 Apr; 10(5):522-30. PubMed ID: 18403232 [TBL] [Abstract][Full Text] [Related]
55. Differential tissue-specific regulation of antiviral CD8+ T-cell immune responses during chronic viral infection. Zhou S; Ou R; Huang L; Price GE; Moskophidis D J Virol; 2004 Apr; 78(7):3578-600. PubMed ID: 15016881 [TBL] [Abstract][Full Text] [Related]
56. Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells. Odorizzi PM; Pauken KE; Paley MA; Sharpe A; Wherry EJ J Exp Med; 2015 Jun; 212(7):1125-37. PubMed ID: 26034050 [TBL] [Abstract][Full Text] [Related]
58. CD40 ligand is pivotal to efficient control of virus replication in mice infected with lymphocytic choriomeningitis virus. Thomsen AR; Nansen A; Christensen JP; Andreasen SO; Marker O J Immunol; 1998 Nov; 161(9):4583-90. PubMed ID: 9794385 [TBL] [Abstract][Full Text] [Related]
59. PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells. West EE; Jin HT; Rasheed AU; Penaloza-Macmaster P; Ha SJ; Tan WG; Youngblood B; Freeman GJ; Smith KA; Ahmed R J Clin Invest; 2013 Jun; 123(6):2604-15. PubMed ID: 23676462 [TBL] [Abstract][Full Text] [Related]
60. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy. Im SJ; Hashimoto M; Gerner MY; Lee J; Kissick HT; Burger MC; Shan Q; Hale JS; Lee J; Nasti TH; Sharpe AH; Freeman GJ; Germain RN; Nakaya HI; Xue HH; Ahmed R Nature; 2016 Sep; 537(7620):417-421. PubMed ID: 27501248 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]